{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:51:39Z","timestamp":1764172299699},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12185-018-2426-2","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T02:09:38Z","timestamp":1520388578000},"page":"329-334","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["EBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus"],"prefix":"10.1007","volume":"108","author":[{"given":"Kimi","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"2426_CR1","first-page":"260","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"J Said","year":"2008","unstructured":"Said J, Cesarman E. Primary effusion lymphoma. In: Swerdblow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 260\u20131."},{"key":"2426_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000097460","volume":"117","author":"Y Kobayashi","year":"2007","unstructured":"Kobayashi Y, Kamitsuji Y, Kuroda J, Tsunoda S, Uoshima N, Kimura S, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acta Haematol. 2007;117:132\u201344.","journal-title":"Acta Haematol"},{"key":"2426_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cncr.23597","volume":"114","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A. PEL and HHV8-unrelated effusion lymphomas: classification and diagnosis. Cancer. 2008;114:225\u20137.","journal-title":"Cancer"},{"key":"2426_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1309\/AJCPHZ3CHO4HUWET","volume":"140","author":"W Wu","year":"2013","unstructured":"Wu W, Youm W, Rezk AS, Zhao X. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma. report of a rare case and review of 54 cases in the literature. Am J Clin Pathol. 2013;140:258\u201373.","journal-title":"Am J Clin Pathol"},{"key":"2426_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12185-011-0906-8","volume":"94","author":"Y Terasaki","year":"2011","unstructured":"Terasaki Y, Yamamoto H, Kiyokawa H, Okumura H, Saito K, Ichinohasama R, et al. Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV negative primary effusion lymphoma-like lymphoma. Int J Hematol. 2011;94:279\u201384.","journal-title":"Int J Hematol"},{"key":"2426_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1081-1206(10)61381-6","volume":"97","author":"L Fonacier","year":"2006","unstructured":"Fonacier L, Charlesworth NE, Spergel MJ, Leung MYD. The black box warning for topical calcineurin inhibitors: looking outside the box. Ann Allergy Asthma Immunol. 2006;97:117\u201320.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2426_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3960\/jslrt.52.211","volume":"52","author":"Y Sekiguchi","year":"2012","unstructured":"Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, et al. Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease: a case report and review of the literature. J Clin Exp Hematol. 2012;52:211\u20138.","journal-title":"J Clin Exp Hematol"},{"key":"2426_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3950\/jibiinkoka.119.741","volume":"119","author":"M Fukasawa","year":"2016","unstructured":"Fukasawa M, Akazawa Y, Kasugai S, Mikami K, Saito Y, Akutsu M, et al. Four cases of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in the head and neck region. Nippon Jibiinkoka Gakkai Kaiho (Tokyo). 2016;119:741\u20139.","journal-title":"Nippon Jibiinkoka Gakkai Kaiho (Tokyo)"},{"key":"2426_CR9","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3109\/10428194.2015.1022769","volume":"56","author":"Y Inui","year":"2015","unstructured":"Inui Y, Matsuoka H, Yakushijin K, Okumura A, Shimada T, Yano S. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma. 2015;56:3045\u201351.","journal-title":"Leuk Lymphoma"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2426-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T20:20:46Z","timestamp":1551903646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2426-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2426"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2426-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"5 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}